Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s stock price dropped 3.8% during trading on Thursday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Trading Down 3.8 %
The stock has a market capitalization of C$52.28 million and a P/E ratio of -0.37. The stock’s 50 day moving average price is C$0.26 and its 200-day moving average price is C$0.26. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
See Also
- Five stocks we like better than Emerald Health Therapeutics
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- What is Insider Trading? What You Can Learn from Insider Trading
- MarketBeat Week in Review – 11/18 – 11/22
- 3 Best Fintech Stocks for a Portfolio Boost
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
